Pear Therapeutics, Inc.: eps_basic
| Value | {"per": "shares", "amount": -0.25, "concept": "us-gaap:EarningsPerShareBasic", "currency": "USD"} |
|---|---|
| Period | 2021-04-01 – 2021-06-30 |
| Status | current |
| Entity | Pear Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/bb8a7b0a-d6cc-4454-a619-4275a2095fc2
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001835567-22-000069 · Open the official SEC filing →Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001835567/eps-basic/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/bb8a7b0a-d6cc-4454-a619-4275a2095fc2
History
- no predecessors — first report